Skip to content
PubMed This is a summary of 108 peer-reviewed journal articles Updated
Cardiology

Coronary Thrombosis: A Patient Guide

At a Glance

Coronary thrombosis is a blood clot in an artery supplying the heart that can block oxygen-rich blood and damage heart muscle. Emergency treatment restores flow, while prescribed antiplatelet therapy and cardiac rehabilitation help reduce the risk of another event.

EMERGENCY WARNING: If you are currently experiencing chest pressure, squeezing, shortness of breath, or other signs of a heart attack, do not drive yourself to the hospital. Call 911 or your local emergency number immediately. This guide is for patients who have already been medically assessed and treated.

Coronary thrombosis is a sudden and critical medical event that occurs when a blood clot forms inside one of the arteries supplying the heart. This process is usually triggered when a fatty deposit, known as a plaque, undergoes a structural change—either by rupturing or eroding—which exposes its contents to the bloodstream. In response, the body’s clotting system activates to seal the “wound,” but the resulting clot can partially or completely block the flow of oxygen-rich blood to the heart muscle [1][2].

When this blockage happens, every minute matters because the heart muscle begins to suffer injury almost immediately. This is why medical teams emphasize that “time is muscle”: the faster the blood flow is restored, the more heart muscle can be saved from permanent damage. This restoration of flow, called reperfusion, is the primary goal of emergency hospital care, whether it is achieved through a specialized procedure to place a stent (angioplasty) or through powerful medications designed to dissolve the clot [3][4].

Once the immediate crisis has passed, the focus shifts toward preventing a recurrence and protecting the healing heart. A cornerstone of this protection is Dual Antiplatelet Therapy (DAPT). Often misunderstood as standard “blood thinners” (anticoagulants), these are specifically antiplatelet medications (like aspirin and a second drug) that keep blood platelets from sticking to the newly placed stent or the damaged artery wall. Adhering strictly to your prescribed regimen is arguably the most important task for a survivor. Stopping these medications without a doctor’s explicit instruction can lead to a sudden, life-threatening clot within the stent, though the exact duration of your therapy will be tailored to your specific risks [5][6].

True recovery, however, extends beyond the medicine cabinet. Long-term health is built through cardiac rehabilitation, a structured program that combines supervised exercise with nutritional guidance and emotional support. By addressing the “whole person”—including smoking cessation, stress management, and heart-healthy lifestyle changes—patients can significantly lower their risk of future events and regain a sense of confidence in their body’s resilience [7][8].

Common questions in this guide

What is coronary thrombosis, and how does it form?
Coronary thrombosis is a blood clot in an artery that supplies the heart. It often starts when fatty plaque ruptures or erodes, exposing material that activates clotting and may partly or completely block oxygen-rich blood flow.
What should I do if I have symptoms of a possible heart attack?
Call 911 or your local emergency number immediately if you have chest pressure, squeezing, shortness of breath, or other possible heart attack symptoms. Do not drive yourself to the hospital.
How is a coronary artery clot treated in the hospital?
The goal is to restore blood flow quickly, a process called reperfusion. Doctors may use angioplasty to place a stent or give medication that dissolves the clot, depending on the situation.
Why are two antiplatelet medicines prescribed after a stent?
Dual antiplatelet therapy, often aspirin plus a second antiplatelet medicine, helps keep platelets from sticking to a new stent or damaged artery wall. Do not stop either medicine unless the prescribing clinician tells you to, because a clot can form in the stent.
How long will I need dual antiplatelet therapy?
The duration is individualized according to your risk of bleeding and your risk of another clot. Ask your cardiology team how long to continue it, and do not change the schedule on your own.
What can help me recover and lower the risk of another event?
Cardiac rehabilitation combines supervised exercise, nutrition guidance, and emotional support. Taking medicines as prescribed, stopping smoking, managing stress, following a heart-healthy diet, and addressing LDL cholesterol can also support long-term heart health.
What should I do about antiplatelet medicines before dental work or surgery?
Tell the dentist or surgeon that you take antiplatelet medicines and ask your cardiology team for a plan before the procedure. Do not stop these medicines on your own, because interruption may increase the risk of a clot in a stent.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my coronary thrombosis caused by a plaque rupture or an erosion, and does that change my recovery plan?
  2. 2.What is the specific target for my LDL cholesterol, and how frequently will we check my levels?
  3. 3.Based on my risk of bleeding versus my risk of a new clot, how long must I stay on my dual antiplatelet therapy (DAPT)?
  4. 4.Can you provide a direct referral to a cardiac rehabilitation program near my home?
  5. 5.If I need to have a dental procedure or minor surgery, what is the protocol for managing my antiplatelet medicines?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (8)
  1. 1

    Pathology of coronary atherosclerosis and thrombosis.

    Otsuka F, Yasuda S, Noguchi T, Ishibashi-Ueda H

    Cardiovascular diagnosis and therapy 2016; (6(4)):396-408 doi:10.21037/cdt.2016.06.01.

    PMID: 27500096
  2. 2

    Update on pathological platelet activation in coronary thrombosis.

    Elia E, Montecucco F, Portincasa P, et al.

    Journal of cellular physiology 2019; (234(3)):2121-2133 doi:10.1002/jcp.27575.

    PMID: 30317596
  3. 3

    Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction.

    Redfors B, Mohebi R, Giustino G, et al.

    Circulation. Cardiovascular interventions 2021; (14(2)):e009879 doi:10.1161/CIRCINTERVENTIONS.120.009879.

    PMID: 33440999
  4. 4

    Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis.

    Foo CY, Bonsu KO, Nallamothu BK, et al.

    Heart (British Cardiac Society) 2018; (104(16)):1362-1369 doi:10.1136/heartjnl-2017-312517.

    PMID: 29437704
  5. 5

    Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks.

    Gorog DA, Ten Berg JM, Campo G, et al.

    European heart journal. Acute cardiovascular care 2026; (15(4)):337-363 doi:10.1093/ehjacc/zuag021.

    PMID: 41914626
  6. 6

    P2Y12 inhibitor monotherapy after abbreviated dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysis.

    Spagnolo M, Imbesi A, Bordonaro CA, et al.

    European heart journal 2026; doi:10.1093/eurheartj/ehag381.

    PMID: 42247196
  7. 7

    Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.

    Brown TM, Pack QR, Aberegg E, et al.

    Circulation 2024; (150(18)):e328-e347 doi:10.1161/CIR.0000000000001289.

    PMID: 39315436
  8. 8

    Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation: Endorsed by the American College of Cardiology.

    Brown TM, Pack QR, Beregg EA, et al.

    Journal of cardiopulmonary rehabilitation and prevention 2025; (45(2)):E6-E25 doi:10.1097/HCR.0000000000000930.

    PMID: 39820221

This page provides general information about coronary thrombosis, emergency treatment, antiplatelet medicines, and recovery; it is for informational purposes only and does not constitute medical advice. For chest pressure, squeezing, shortness of breath, or other possible heart attack symptoms, call emergency services rather than driving yourself.

Get notified when new evidence is published on coronary thrombosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.